From: Post-transplant lymphoproliferative disorder (PTLD): single institutional experience of 141 patients
PTLD Pathology | Sub-types | B-cell subtype | n | % | p-value | Hazard ratios | 95% confidence limits |
---|---|---|---|---|---|---|---|
Early lesion PTLD |  |  | 11 | 7.8 | 0.9859 | 0.000 | 0.000–0.000 |
Plasmacytic hyperplasia PTLD | Â | 4 | 2.8 | Â | Â | Â | |
Infectious mononucleosis PTLD | Â | 3 | 2.1 | Â | Â | Â | |
Florid follicular hyperplasia PTLD | Â | 4 | 2.8 | Â | Â | Â | |
Polymorphic PTLD |  |  | 27 | 19.1 | 0.6011 | 0.832 | 0.417–1.660 |
Monomorphic PTLD (B- and T-/NK-cell types) |  |  | 97 | 68.8 | 0.0177 | 2.309 | 1.156–4.609 |
B-cell |  | 89 | 63.1 | 0.6285 | 0.790 | 0.304–2.054 | |
 | DLBCL | 60 | 42.6 | 0.2096 | 1.413 | 0.823–2.426 | |
 | Burkitt | 9 | 6.4 |  |  |  | |
 | Plasma cell myeloma/Plasmacytoma like lesion | 6 | 4.3 |  |  |  | |
 | Follicular | 2 | 1.4 |  |  |  | |
 | Other B-cell type | 2 | 1.4 |  |  |  | |
 | Unspecified | 10 | 7.1 |  |  |  | |
T-/NK-cell | Â | 8 | 5.7 | Â | Â | Â | |
Classical Hodgkin lymphoma PTLD |  |  | 5 | 3.5 | 0.9852 | 0.000 | 0.000–0.000 |
Unknown | Â | Â | 1 | 0.7 | Â | Â | Â |